These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 34906201
1. Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers. Murff HJ, Greevy RA, Sanghani RS, Hartmann KE, Hartert TV, Graves CR, Lee SS, Tindle HA. Trials; 2021 Dec 14; 22(1):922. PubMed ID: 34906201 [Abstract] [Full Text] [Related]
2. The effect of omega-3 supplementation on pregnancy outcomes by smoking status. Kuper SG, Abramovici AR, Jauk VC, Harper LM, Biggio JR, Tita AT. Am J Obstet Gynecol; 2017 Oct 14; 217(4):476.e1-476.e6. PubMed ID: 28549983 [Abstract] [Full Text] [Related]
3. Randomized Trial of Nicotine Inhaler for Pregnant Smokers. Oncken C, Dornelas EA, Kuo CL, Sankey HZ, Kranzler HR, Mead EL, Thurlow MSD. Am J Obstet Gynecol MFM; 2019 Mar 14; 1(1):10-18. PubMed ID: 31380506 [Abstract] [Full Text] [Related]
4. The Fish Oil to Reduce Tobacco Use iN Expectant mothers (FORTUNE) feasibility trial. Murff HJ, Greevy RA, Sternlieb S, Gilliam K, King S, Sanghani R, Tindle HA. Am J Obstet Gynecol MFM; 2022 Nov 14; 4(6):100707. PubMed ID: 35948268 [Abstract] [Full Text] [Related]
5. A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery. Makrides M, Best K, Yelland L, McPhee A, Zhou S, Quinlivan J, Dodd J, Atkinson E, Safa H, van Dam J, Khot N, Dekker G, Skubisz M, Anderson A, Kean B, Bowman A, McCallum C, Cashman K, Gibson R. N Engl J Med; 2019 Sep 12; 381(11):1035-1045. PubMed ID: 31509674 [Abstract] [Full Text] [Related]
6. DHA supplementation and pregnancy outcomes. Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ. Am J Clin Nutr; 2013 Apr 12; 97(4):808-15. PubMed ID: 23426033 [Abstract] [Full Text] [Related]
7. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, Coleman T, Smoking, Nicotine and Pregnancy (SNAP) Trial Team. Lancet Respir Med; 2014 Sep 12; 2(9):728-37. PubMed ID: 25127405 [Abstract] [Full Text] [Related]
8. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial. Zhou SJ, Best K, Gibson R, McPhee A, Yelland L, Quinlivan J, Makrides M. BMJ Open; 2017 Sep 24; 7(9):e018360. PubMed ID: 28947468 [Abstract] [Full Text] [Related]
9. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Cooper S, Lewis S, Thornton JG, Marlow N, Watts K, Britton J, Grainge MJ, Taggar J, Essex H, Parrott S, Dickinson A, Whitemore R, Coleman T, Smoking, Nicotine and Pregnancy Trial Team. Health Technol Assess; 2014 Aug 24; 18(54):1-128. PubMed ID: 25158081 [Abstract] [Full Text] [Related]
10. Dietary PUFA for preterm and term infants: review of clinical studies. Fleith M, Clandinin MT. Crit Rev Food Sci Nutr; 2005 Aug 24; 45(3):205-29. PubMed ID: 16048149 [Abstract] [Full Text] [Related]
11. ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth. Best KP, Gibson RA, Makrides M. Prostaglandins Leukot Essent Fatty Acids; 2022 Nov 24; 186():102495. PubMed ID: 36228573 [Abstract] [Full Text] [Related]
12. Fish Oil Supplementation in Pregnancy Increases Gestational Age, Size for Gestational Age, and Birth Weight in Infants: A Randomized Controlled Trial. Vinding RK, Stokholm J, Sevelsted A, Chawes BL, Bønnelykke K, Barman M, Jacobsson B, Bisgaard H. J Nutr; 2019 Apr 01; 149(4):628-634. PubMed ID: 30418579 [Abstract] [Full Text] [Related]
13. Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy. Best KP, Gibson RA, Yelland LN, Leemaqz S, Gomersall J, Liu G, Makrides M. Prostaglandins Leukot Essent Fatty Acids; 2020 Nov 01; 162():102181. PubMed ID: 33038832 [Abstract] [Full Text] [Related]
14. Impact of n-3 polyunsaturated fatty acid intake in pregnancy on maternal health and birth outcomes: systematic review and meta-analysis from randomized controlled trails. Abdelrahman MA, Osama H, Saeed H, Madney YM, Harb HS, Abdelrahim MEA. Arch Gynecol Obstet; 2023 Jan 01; 307(1):249-262. PubMed ID: 35348829 [Abstract] [Full Text] [Related]
15. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. Allen SI, Foulds J, Pachas GN, Veldheer S, Cather C, Azzouz N, Hrabovsky S, Hameed A, Yingst J, Hammett E, Modesto J, Krebs NM, Zhu J, Liao J, Muscat JE, Richie J, Evins AE. BMC Public Health; 2017 Jan 19; 17(1):100. PubMed ID: 28103841 [Abstract] [Full Text] [Related]
16. Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. Simmonds LA, Sullivan TR, Skubisz M, Middleton PF, Best KP, Yelland LN, Quinlivan J, Zhou SJ, Liu G, McPhee AJ, Gibson RA, Makrides M. BJOG; 2020 Jul 19; 127(8):975-981. PubMed ID: 32034969 [Abstract] [Full Text] [Related]
17. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM). Lorthe E, Kayem G, TOCOPROM Study Group and the GROG (Groupe de Recherche en Obstétrique et Gynécologie). BMC Pregnancy Childbirth; 2021 Sep 08; 21(1):614. PubMed ID: 34496799 [Abstract] [Full Text] [Related]
18. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. Pediatrics; 2014 Jul 08; 134(1):120-34. PubMed ID: 24913791 [Abstract] [Full Text] [Related]
19. Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial. Sjöbom U, Andersson MX, Pivodic A, Lund AM, Vanpee M, Hansen-Pupp I, Ley D, Wackernagel D, Sävman K, Smith LEH, Löfqvist C, Hellström A, Nilsson AK. Clin Nutr; 2023 Jun 08; 42(6):962-971. PubMed ID: 37120902 [Abstract] [Full Text] [Related]
20. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Harper M, Thom E, Klebanoff MA, Thorp J, Sorokin Y, Varner MW, Wapner RJ, Caritis SN, Iams JD, Carpenter MW, Peaceman AM, Mercer BM, Sciscione A, Rouse DJ, Ramin SM, Anderson GD, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol; 2010 Feb 08; 115(2 Pt 1):234-242. PubMed ID: 20093894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]